ResMed Inc. Announces Third Quarter Fiscal Year 2026 Results and Declares Quarterly Dividend

ResMed Inc. reported strong financial results for the third quarter of fiscal year 2026, with revenue increasing by 11% to $1.4 billion (8% on a constant currency basis). The company saw improvements in gross margin, with GAAP gross margin up 290 basis points to 62.2% and non-GAAP gross margin up to 62.8%. Income from operations increased by 17% (18% non-GAAP), and diluted earnings per share were $2.74 ( $2.86 non-GAAP). Operating cash flow was $554 million. ResMed also announced a quarterly cash dividend of $0.60 per share, payable on June 18, 2026. The company highlighted strategic progress, including product launches and operational expansions, and continued focus on global care access and digital health solutions.